Illuminating drug discovery with biological pathways

被引:82
|
作者
Apic, G
Ignjatovic, T
Boyer, S
Russell, RB
机构
[1] Cambridge Cell Networks, Cambridge CB3 0FD, England
[2] AstraZeneca R&D, Safety Assessment, S-43183 Molndal, Sweden
[3] EMBL, D-69112 Heidelberg, Germany
关键词
systems biology; drug discovery; biological pathways;
D O I
10.1016/j.febslet.2005.02.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Systems biology promises to impact significantly on the drug discovery process. One of its ultimate goals is to provide an understanding of the complete set of molecular mechanisms describing an organism. Although this goal is a long way off, many useful insights can already come from currently available information and technology. One of the biggest challenges in drug discovery today is the high attrition rate: many promising candidates prove ineffective or toxic owing to a poor understanding of the molecular mechanisms of biological systems they target. A "systems" approach can help identify pathways related to a disease and can suggest secondary effects of drugs that might cause these problems and thus ultimately improve the drug discovery pipeline. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1872 / 1877
页数:6
相关论文
共 50 条
  • [1] Illuminating drug discovery
    Contag, CH
    Contag, PR
    CHEMISTRY & INDUSTRY, 1999, (17) : 664 - 666
  • [2] Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma
    Choonoo, Gabrielle
    Blucher, Aurora S.
    Higgins, Samuel
    Boardman, Mitzi
    Jeng, Sophia
    Zheng, Christina
    Jacobs, James
    Anderson, Ashley
    Chamberlin, Steven
    Evans, Nathaniel
    Vigoda, Myles
    Cordier, Benjamin
    Tyner, Jeffrey W.
    Kulesz-Martin, Molly
    McWeeney, Shannon K.
    Laderas, Ted
    PLOS ONE, 2019, 14 (10):
  • [3] An illuminating discovery
    Catlin, George
    EDN, 2011, 56 (12) : 58 - 58
  • [4] Pathways to drug discovery in CNS
    Andersen, P. H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 40 - 40
  • [5] Illuminating discovery
    不详
    CHEMISTRY IN BRITAIN, 1998, 34 (05) : 18 - 18
  • [6] Antimycobacterial Metabolism: Illuminating Mycobacterium tuberculosis Biology and Drug Discovery
    Awasthi, Divya
    Freundlich, Joel S.
    TRENDS IN MICROBIOLOGY, 2017, 25 (09) : 756 - 767
  • [7] Biological simulations in drug discovery
    Noble, D
    Levin, J
    Scott, W
    DRUG DISCOVERY TODAY, 1999, 4 (01) : 10 - 16
  • [8] Pathways to new drug discovery in neuropsychiatry
    Berk, Michael
    BMC MEDICINE, 2012, 10
  • [9] Redox pathways in cancer drug discovery
    Tew, Kenneth D.
    Ali-Osman, Francis
    CURRENT OPINION IN PHARMACOLOGY, 2007, 7 (04) : 353 - 354
  • [10] Pathways to new drug discovery in neuropsychiatry
    Michael Berk
    BMC Medicine, 10